INTELLIA THERAPEUTICS INC's ticker is NTLA and the CUSIP is 45826J105. A total of 342 filers reported holding INTELLIA THERAPEUTICS INC in Q2 2021. The put-call ratio across all filers is 0.72 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $63,240 | -23.2% | 2,000 | -1.0% | 0.01% | -27.3% |
| Q2 2023 | $82,376 | +9.4% | 2,020 | 0.0% | 0.01% | 0.0% |
| Q1 2023 | $75,285 | -23.5% | 2,020 | -28.4% | 0.01% | -26.7% |
| Q4 2022 | $98,390 | -45.3% | 2,820 | -12.4% | 0.02% | -50.0% |
| Q3 2022 | $180,000 | +7.8% | 3,220 | 0.0% | 0.03% | +11.1% |
| Q2 2022 | $167,000 | -28.6% | 3,220 | 0.0% | 0.03% | -12.9% |
| Q1 2022 | $234,000 | -61.7% | 3,220 | -37.7% | 0.03% | -59.7% |
| Q4 2021 | $611,000 | -29.0% | 5,170 | -19.3% | 0.08% | -34.2% |
| Q3 2021 | $860,000 | +343.3% | 6,410 | +434.2% | 0.12% | +350.0% |
| Q2 2021 | $194,000 | +708.3% | 1,200 | +300.0% | 0.03% | +550.0% |
| Q1 2021 | $24,000 | +242.9% | 300 | -40.0% | 0.00% | +100.0% |
| Q4 2019 | $7,000 | – | 500 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Discovery Value Fund | 561,561 | $17,756,559 | 9.73% |
| MPM BioImpact LLC | 544,639 | $17,221,485 | 4.60% |
| Casdin Capital, LLC | 1,178,075 | $37,250,732 | 4.12% |
| HIMENSION CAPITAL (SINGAPORE) PTE. LTD. | 1,145,091 | $36,207,777 | 3.72% |
| Atlas Venture Associates IX, LLC | 10,000 | $316,200 | 2.69% |
| Deep Track Capital, LP | 2,000,000 | $63,240,000 | 2.44% |
| ARK Investment Management | 9,948,629 | $314,575,638 | 2.41% |
| Merlin Capital, Inc | 18,526 | $585,792 | 2.19% |
| Orchard Capital Management, LLC | 159,155 | $5,032,481 | 1.86% |
| TANG CAPITAL MANAGEMENT LLC | 397,600 | $12,572,112 | 1.77% |